0

Amitriptyline Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21659

Download Sample Report download
Buy the Full ReportStarting from $3999
Published on

January 2022

Total pages

248

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3999

About the Report

About the Report

Amitriptyline is a drug that affects certain chemical messengers (neurotransmitters) which communicate between the cells of the brain and help in regulating mood. It is a tricyclic antidepressant that is used in the treatment of various health conditions such as chronic neuropathic pain, depression, migraine, and others.

As per the American Psychological Association, in 2019, over three-quarters of adults report symptoms of stress, including headache, tiredness, or sleeping problems. Also, in 2020, almost 91% of Australians feels stressed about one or more important parts of their life. This increased level of stress among the population across the world has been causing disorders such as depression which in turn is boosting the amitriptyline market as it is a tricyclic antidepressant. For instance, as per the WHO, one of the leading causes of disability around the globe is depression. More than 264 million people suffer from depression globally in 2020. this number is expected to increase in the upcoming years which will also positively impact the demand for the antidepressants such as amitriptyline in the forecast period.

Additionally, Amitriptyline is also an effective, inexpensive and off-label drug used for preventing migraine and tension-type headaches. Migraine is the third most common disease in the world, according to the Migraine Research Foundation. In 2019, almost 1 billion has been affected by migraine. This drug is also given in combination with other salts such as Anxipan which combines amitriptyline and pantoprazole. This is also contributing to the growth of the amitriptyline market. However, the side effects associated with the drug and the availability of alternative treatments are some of the factors impeding the growth of the market.

Based on strength, the amitriptyline market is segmented into 10 mg tablets, 25 mg tablets, 50 mg tablets, 75 mg tablets, 100 mg tablets, and 150 mg tablets. The 10 mg tablets segment generated revenue of USD XX million in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027.

Based on indication, the market is segmented into depression, migraine, nocturnal enuresis, chronic neuropathic pain, and others. The chronic neuropathic pain segment grabbed XX% market share of the amitriptyline market and gathered revenue of USD XX million in 2020. The segment is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027.

Based on the distribution channel, the market is fragmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment captured XX% market share in 2020. The market of this segment is expected to reach USD XX million by 2027.

For a better understanding of the market adoption of the amitriptyline, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the amitriptyline industry and generated revenue of USD XX Million in 2020 owing to the presence of well-established market players in the region.

Some of the major players operating in the market are Accord Healthcare Inc., Mylan Pharmaceuticals Inc., Sandoz Inc., Sun Pharmaceutical Industries, Vintage Pharmaceuticals Inc., Zydus Pharmaceuticals USA Inc., Watson Laboratories Inc., Torrent Pharmaceuticals Ltd., among others. Several M&A's along with partnerships have been undertaken by these players to develop new products.

The Global Amitriptyline Market was valued at USD XX million in 2020 and is projected to expand significantly with a CAGR of XX% from 2021 to 2027. The Amitriptyline market is expected to witness a boost, owing to the surge in the number of people suffering from depression and neuropathic pain.

Products


Companies

Accord Healthcare Inc., Mylan Pharmaceuticals Inc., Sandoz Inc., Sun Pharmaceutical Industries, Vintage Pharmaceuticals Inc., Zydus Pharmaceuticals USA Inc., Watson Laboratories Inc., Torrent Pharmaceuticals Ltd.

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Amitriptyline Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Amitriptyline Market

2.1.1 Main Objective of the Global Amitriptyline Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 GLOBAL AMITRIPTYLINE MARKET REVENUE

7 MARKET INSIGHTS BY STRENGTH

7.1 10 mg tablets

7.2 25 mg tablets

7.3 50 mg tablets

7.4 75 mg tablets

7.5 100 mg tablets

7.6 150 mg tablets

8 MARKET INSIGHTS BY INDICATION

8.1 Depression

8.2 Migraine

8.3 Nocturnal Enuresis

8.4 Chronic Neuropathic Pain

8.5 Others

9 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

9.1 Hospital Pharmacies

9.2 Retail Pharmacies

9.3 Online Pharmacies

10 MARKET INSIGHTS BY REGION

10.1 NORTH AMERICA AMITRIPTYLINE MARKET

10.1.1 United States

10.1.2 Canada

10.1.3 Rest of North America

10.2 EUROPE AMITRIPTYLINE MARKET

10.2.1 Germany

10.2.2 France

10.2.3 United Kingdom

10.2.4 Spain

10.2.5 Italy

10.2.6 Rest of Europe

10.3 ASIA PACIFIC AMITRIPTYLINE MARKET

10.3.1 China

10.3.2 Japan

10.3.3 India

10.3.4 Australia

10.3.5 Rest of Asia Pacific

10.4 REST OF THE WORLD AMITRIPTYLINE MARKET

11 AMITRIPTYLINE MARKET DYNAMICS

11.1 Market Drivers

11.2 Market Challenges

11.3 Impact Analysis

12 AMITRIPTYLINE MARKET OPPORTUNITIES

13 AMITRIPTYLINE MARKET TRENDS & INSIGHTS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

15.1 Demand Side Analysis

15.2 Supply Side Analysis

15.2.1 Top Product Launches

15.2.2 Top Business Partnerships

15.2.3 Top Merger & Acquisitions

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

17.1 Porter's Five forces analysis

17.1.1 Bargaining power of Supplier

17.1.2 Bargaining power of Buyer

17.1.3 Industry Rivalry

17.1.4 Availability of Substitute

17.1.5 Threat of new Entrants

18 COMPANY PROFILED

18.1 Accord Healthcare Inc.

18.1.1 Key Facts

18.1.2 Business Description

18.1.3 Key Product/Services Offerings

18.1.4 Growth Strategy

18.1.5 SWOT Analysis

18.1.6 Key Financials

18.1.6.1 Revenue Split

18.1.6.2 Financial Overview of Accord Healthcare Inc.

18.1.7 Recent Developments

18.1.7.1 Product Launch

18.1.7.2 Partnerships

18.1.7.3 Business Expansion and Investments

18.1.7.4 Merger and Acquisition

18.2 Mylan Pharmaceuticals Inc.

18.3 Sandoz Inc.

18.4 Sun Pharmaceutical Industries

18.5 Vintage Pharmaceuticals Inc.

18.6 Zydus Pharmaceuticals USA Inc.

18.7 Watson laboratories Inc.

18.8 Torrent Pharmaceuticals Ltd.

19 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022